Zinc Oxide Pharma

Product description

With over 100 years of experience, Grillo Zinkoxid GmbH is one of the market leaders in developing and producing zinc oxides in different qualities. As a traditional and family-owned company, Grillo offers customer-focused solutions for various uses of zinc oxides. The products are ideally suited for providing end-to-end service for customers focusing on areas of treatment such as skin and wounds.

The pharmaceutically pure zinc oxides from Grillo Zinkoxid GmbH are produced from high-purity SHG zinc by the indirect process (French Process) in compliance with Good Manufacturing Practice (EU-GMP guidelines Part II).

Zinc oxide can be used as active ingredient or excipient in numerous pharmaceutical and cosmetic applications such as skin creams, and pastes, but also in medical applications such as wound dressings and the vulcanization of rubber stoppers.

Registration no. of zinc oxide by Grillo Zinkoxid GmbH: DE_NI_01_Reg_2017_0001

Tradename Specific surface area range (m²/g)
Zinc Oxide Pharma 4 API BET 3,0-5,0
Zinc Oxide Pharma 6 API BET 5,1-7,0
Zinc Oxide Pharma 8 API BET 7,1-9,0
Zinc Oxide Pharma 4 Excipient BET 3,0-5,0
Zinc Oxide Pharma 6 Excipient BET 5,1-7,0
Zinc Oxide Pharma 8 Excipient BET 7,1-9,0



Country availability

Austria Denmark
Estonia Finland
Germany Greece
Italy Latvia
Lithuania Norway
Poland Singapore
Spain Sweden
Switzerland Thailand
Nina Allers

Contact person

Nina Allers

Product Manager Healthcare

email   phone

Further information


pdf (6.1 MB)


Spotlight Zinc Oxide
pdf (444.4 KB)